soul trial oral semaglutide cardiovascular outcomes 2024 2025 results 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM PDF) Oral Semaglutide and Cardiovascular

Novo Nordisk offers a discount and savings program, where you can receive up to $60 off a single box of pen needles

GLP1T-36HK allows quantification of all forms of GLP-1 (736) amide, GLP-1 (737), GLP-1 (936) amide, GLP-1 (937), GLP-1 (136) amide, and GLP-1 (137)

Hematol Oncol Stem Cell Ther 13(2):8590 Piel FB, Steinberg MH, Rees DC (2017) Sickle cell disease

Some say Holst is a future Nobel Prize winner for this work, while others say he helped further fuel a wildly expensive industry to treat something better addressed with diet and exercise

Im always skeptical of how much some of the reported side effects (hair loss, etc.) indirectly have to do with malnutrition and not properly nourishing your body while on the medication vs anything directly related to medication mechanism itself

If you fall into any of those categories and experience symptoms, seek medical care